These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
250 related articles for article (PubMed ID: 9433781)
1. Synthesis and antitumor activity of fused quinoline derivatives. V. Methylindolo[3,2-b]quinolines. Takeuchi Y; Kitaomo M; Chang MR; Shirasaka S; Shimamura C; Okuno Y; Yamato M; Harayama T Chem Pharm Bull (Tokyo); 1997 Dec; 45(12):2096-9. PubMed ID: 9433781 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and antitumor activity of fused quinoline derivatives. III. Novel N-glycosylamino-indolo[3,2-b]quinolines. Takeuchi Y; Chang MR; Hashigaki K; Tashiro T; Tsuruo T; Tsukagoshi S; Yamato M Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1481-5. PubMed ID: 1394666 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumor activity of 7-(N-glycosylamino)-indolo[3,2-b]quinolines. Takeuchi Y; Chang MR; Hashigaki K; Yamato M Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1629-31. PubMed ID: 1934189 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor activity of fused quinoline derivatives. II. Novel 4- and 7-hydroxyindolo-[3,2-b]quinolines. Yamato M; Takeuchi Y; Chang MR; Hashigaki K Chem Pharm Bull (Tokyo); 1992 Feb; 40(2):528-30. PubMed ID: 1606653 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and in vitro antiproliferative activity of new 11-aminoalkylamino-substituted 5H- and 6H-indolo[2,3-b]quinolines; structure-activity relationships of neocryptolepines and 6-methyl congeners. Wang L; Switalska M; Mei ZW; Lu WJ; Takahara Y; Feng XW; El-Sayed Iel-T; Wietrzyk J; Inokuchi T Bioorg Med Chem; 2012 Aug; 20(15):4820-9. PubMed ID: 22748378 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationship of methyl-substituted indolo[2,3-b]quinolines: novel cytotoxic, DNA topoisomerase II inhibitors. Peczyńska-Czoch W; Pognan F; Kaczmarek L; Boratyński J J Med Chem; 1994 Oct; 37(21):3503-10. PubMed ID: 7932579 [TBL] [Abstract][Full Text] [Related]
7. Synthesis, antitumor evaluation and SAR of new 1H-pyrrolo [3,2-c] quinoline-6,9-diones and 11H-indolo [3,2-c] quinoline-1,4-diones. Helissey P; Cros S; Giorgi-Renault S Anticancer Drug Des; 1994 Feb; 9(1):51-67. PubMed ID: 8141966 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and antitumor activity of fused quinoline derivatives. IV. Novel 11-aminoindolo[3,2-b]quinolines. Takeuchi Y; Oda T; Chang MR; Okamoto Y; Ono J; Oda Y; Harada K; Hashigaki K; Yamato M Chem Pharm Bull (Tokyo); 1997 Feb; 45(2):406-11. PubMed ID: 9118455 [TBL] [Abstract][Full Text] [Related]
9. [Synthesis of potential antitumor agents: nitrogen mustards based on quinoline]. Pellerano C; Savini L Farmaco Sci; 1984 Aug; 39(8):681-5. PubMed ID: 6479326 [TBL] [Abstract][Full Text] [Related]
10. Design of antineoplastic agents based on the '2-phenylnaphthalene-type' structural pattern--synthesis and biological activity studies of 11H-indolo[3.2-c]quinoline derivatives. He L; Chang HX; Chou TC; Savaraj N; Cheng CC Eur J Med Chem; 2003 Jan; 38(1):101-7. PubMed ID: 12593920 [TBL] [Abstract][Full Text] [Related]
11. A convenient synthesis of 1H-pyrrolo[3,2-c]quinoline-6,9-diones and 11H-indolo[3,2-c]quinoline-1,4-diones derivatives. Helissey P; Parrot-Lopez H; Renault J; Cros S Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3547-57. PubMed ID: 3435963 [No Abstract] [Full Text] [Related]
12. Heterocyclic quinones. XIV. Pharmacomodulation in a series of 11H-indolo[3,2-c]quinolinediones: synthesis and cytotoxicity of 8-substituted 11H-indolo[3,2-c]quinoline-7,10-diones. Helissey P; Giorgi-Renault S; Renault J; Cros S Chem Pharm Bull (Tokyo); 1989 Mar; 37(3):675-9. PubMed ID: 2752476 [TBL] [Abstract][Full Text] [Related]
13. Synthesis, and cytotoxic activity of some novel indolo[2,3-b]quinoline derivatives: DNA topoisomerase II inhibitors. Kaczmarek L; Peczyńska-Czoch W; Osiadacz J; Mordarski M; Sokalski WA; Boratyński J; Marcinkowska E; Glazman-Kuśnierczyk H; Radzikowski C Bioorg Med Chem; 1999 Nov; 7(11):2457-64. PubMed ID: 10632055 [TBL] [Abstract][Full Text] [Related]
14. Design and synthesis of isoindoloquinoline derivatives as potential antitumor agents. Lee H; Jeong I; Yang SI Arch Pharm Res; 2002 Aug; 25(4):416-20. PubMed ID: 12214847 [TBL] [Abstract][Full Text] [Related]
15. [Synthesis and biological activity of new compounds with the 1,3-dioxol(4,5-g)quinoline structure]. Pellerano C; Savini L Farmaco Sci; 1984 Jul; 39(7):640-8. PubMed ID: 6479323 [TBL] [Abstract][Full Text] [Related]
16. Synthesis of 4-quinolylazide derivatives and evaluation of their antitumor and antimicrobial activity. Savini L; Massarelli P; Pellerano C Farmaco; 1993 Apr; 48(4):515-28. PubMed ID: 8357467 [TBL] [Abstract][Full Text] [Related]
17. Heterocyclic quinones. XVI. Pharmacomodulation in the series of 11H-indolo[3,2-c]quinolinediones: synthesis, cytotoxicity and antitumor activity of 3-substituted 11H-pyrido[3',4':4,5]pyrrolo[3,2-c]quinoline-1,4-diones. Helissey P; Giorgi-Renault S; Renault J; Cros S Chem Pharm Bull (Tokyo); 1989 Sep; 37(9):2413-6. PubMed ID: 2557983 [TBL] [Abstract][Full Text] [Related]
18. New derivatives of 11-methyl-6-[2-(dimethylamino)ethyl]-6H-indolo[2,3-b]quinoline as cytotoxic DNA topoisomerase II inhibitors. Luniewski W; Wietrzyk J; Godlewska J; Switalska M; Piskozub M; Peczynska-Czoch W; Kaczmarek L Bioorg Med Chem Lett; 2012 Oct; 22(19):6103-7. PubMed ID: 22944121 [TBL] [Abstract][Full Text] [Related]
19. Synthesis and anticancer evaluation of certain indolo[2,3-b]quinoline derivatives. Chen YL; Hung HM; Lu CM; Li KC; Tzeng CC Bioorg Med Chem; 2004 Dec; 12(24):6539-46. PubMed ID: 15556770 [TBL] [Abstract][Full Text] [Related]
20. Ultrasound-assisted Synthesis of 6-substituted indolo[2,3-b]quinolines: their Evaluation as Potential Cytotoxic Agents. Marepu N; Gosi M; Vedula SS; Yeturu S; Pal M Mini Rev Med Chem; 2019; 19(7):599-608. PubMed ID: 30058486 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]